Increased lithium levels in water could increase the risk of autism.

Published Date: 05 Apr 2023

A new study led by a UCLA Health researcher found that pregnant women had a slightly increased risk of having children with autism spectrum disorder if the household tap water had higher lithium levels.

Read Full News

Latest News

Certain Multiple Sclerosis Drugs Tied to Lower Uveitis Risk

The use of nucleic acid synthesis inhibitors or sphingosine-1-phosphate modulators, fumarates, or interferons is linked to a lower risk for noninfectious uveitis in patients with MS, a new study finds.

HHS Pushes to Stop ‘Overprescribing’ of Psychiatric Meds

A new HHS action plan aims to curb psychiatric drug “overprescribing” and expand nonmedication mental health care, drawing criticism from the APA.

When Retirement Triggers Risk: Substance Use in Older Adults

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Personalized Stimulation Boosts Outcomes in Essential Tremor

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

Adjunctive CBD Improves Neuropsychiatric Symptoms in TSC

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

What Drives 50-Day Neurology Wait Times? Not Just Supply

The average wait time for a first neurology appointment is nearly 50 days for commercially insured patients. The cause may not be what you think.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

The use of nucleic acid synthesis inhibitors or sphingosine-1-phosphate modulators, fumarates, or interferons is linked to a lower risk for noninfectious uveitis in patients with MS, a new study finds.

A new HHS action plan aims to curb psychiatric drug “overprescribing” and expand nonmedication mental health care, drawing criticism from the APA.

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

The average wait time for a first neurology appointment is nearly 50 days for commercially insured patients. The cause may not be what you think.

News All Time

New Evidence Strengthens the Case for Iatrogenic Alzheimer’s

Researchers report the first autopsy-confirmed case of Alzheimer's disease following suspected medical transmission, but experts say definitive causation may remain elusive.

Experts Push Back on WHO’s ‘Misleading’ Portrayal of ECT

Leading psychiatry groups say WHO guidance on ECT risks stigmatizing and reducing access to a safe, effective, and sometimes life-saving treatment for patients with severe mental illness.

Do Early Birds Have a Lower Risk for ALS?

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new study shows.

Halting MOGAD Treatment Tied to Lower Relapse Risk

Stopping treatment for myelin oligodendrocyte glycoprotein antibody-associated disease is linked to fewer relapses than treatment continuation, new research shows.

FDA OKs Drug to Treat Neurologic Symptoms in Hunter Syndrome

The U.S. Food and Drug Administration has approved Denali Therapeutics' therapy to treat children ⁠with a rare genetic disorder, marking the first regulatory green light for...

FDA Seeks New Warning for Certain Parkinson's Drugs

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

Scottish Lawmakers Vote Against Allowing Assisted Dying

Scottish lawmakers have voted against legalising assisted, crushing hopes for a historic law change, ⁠as similar proposals in England and Wales also look set to fail.

Little Evidence of Cannabis Efficacy for Psychiatric Illness

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Prenatal Antiseizure Med Exposure: Risks Vary by Agent

A large cohort study sheds new light on neurodevelopmental risk in children after prenatal antiseizure medication exposure, with variation across individual agents.

Anxiety and Depression May Raise Risk for Aneurysm Rupture

Anxiety and depression are linked to an increased risk for rupture and mortality in patients with unruptured intracranial aneurysms, a new cohort study shows.

China Approves Market Launch Of Brain-computer Interface Medical Device in World First

China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system ⁠that helps restore hand-movement ability to be sold, the world's...

Why Aren’t Canadians Getting Enough Sleep?

The change to daylight saving time and the marking of World Sleep Day call attention to the factors that contribute to sleep deficits among Canadians.

Single IV Ketamine Promising for Depression in MCI

Ketamine is well-tolerated in older adults with both mild cognitive impairment and depression and associated with improved depression scores, a new study shows.

Late Complications Common After CVT, Even After Recovery

Although a majority of patients with cerebral venous sinus thrombosis achieve independence, 1 in 3 may develop delayed complications such as seizures, a study shows.

Activity Trackers May Predict MS Progression

Reduced daytime physical activity, as measured with wearable trackers, is tied to increased risk for multiple sclerosis progression and brain atrophy, new research shows.

WHO Warns Of Health Risks From 'Black Rain' in Iran

The World Health Organization warned on Tuesday that the 'black rain' and toxic compounds in the air in Iran after strikes on ⁠oil facilities could cause respiratory problems.

Recommended News For You

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

Chris Hoy reveals that he has terminal cancer?here's how to spot early signs of prostate cancer

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Recommended Articles For You

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance 

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Navigating the Stages of Thyroid Cancer: A Guide for Patients 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

3D virtual staining technology enables non-invasive observation of cancer tissue

2.

Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.

3.

BMI is linked to heart damage from chemotherapy in breast cancer patients.

4.

New Gene Therapy Nears EU Nod for Bladder Cancer

5.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

1.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

2.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

3.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

4.

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium

5.

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot